The company has not filed an annual or quarterly report since its FY2023 20-F, filed May 15, 2024. Its latest SEC filing is a SEC STAFF ACTION from Jun 30, 2025.
20-F for FY2023, filed May 15, 2024
The sections below describe the company as of the FY2023 annual report.
Provides remote pregnancy monitoring through its INVU wearable sensor band and digital platform to healthcare systems and obstetrician practices.
20-F for FY2023, filed May 15, 2024INVU is composed of a hardware component (wearable), with digital signal processing and cloud analytics, and interfaces for every…View ↗
In addition to the FDA clearances mentioned above, we also received ISO 13485 certification in February 2020 for the development…View ↗
Commercial customers are healthcare providers with an installed base of clinicians that understand how to prescribe and use our INVU…View ↗
Healthcare providers pay for pregnancy monitoring services using the leased sensor band and the company’s cloud platform; under the subscription model, they pay a fixed fee for each prescribed monitoring episode.
20-F for FY2023, filed May 15, 2024
$176K
20-F for FY2023, filed May 16, 2024
$176K ↗
The company sells directly to hospital and healthcare systems and to private practices, including physician practice management groups. It also serves customers through distributors.
20-F for FY2023, filed May 15, 2024
No. It lost $33.7M in FY2023.
Loading...